Alfa Aesar

Biomedical Technologies (BT), now part of Alfa Aesar, specializes in the production of high quality lipoprotein reagents for cardiovascular disease research. We offer native human lipoproteins, and also oxidized, acetylated or carbamylated low density lipoproteins. Additionally, we provide fluorescently labelled lipoproteins. These fluorescent reagents conveniently label cultured cells for identification, isolation or quantification of receptor site activity. All of our lipoproteins are membrane filtered and aseptically filled, and some are endotoxin tested.